TTC17 and breast cancer: Furthermore, considering the regulatory role of TTC17 on the actin cytoskeleton, we wondered whether TTC17 expression would affect the efficacy of the anti-microtubule chemotherapeutic agent paclitaxel, which is a common chemotherapeutic drug in routine BC treatment and was also indicated by drug library screening in BC.